Sign in: I am an APHA member
Sign in: I am an online subscriber
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
Jump to section
- Top
- How diverse are clinical trials in the U.S. currently? Where are the biggest gaps?
- What are the public health consequences of a lack of diversity in clinical trials?
- What are the barriers to achieving diversity in clinical trials?
- FDA itself does not conduct clinical trials. How does diversity in clinical trials affect FDA’s work? How did this become a focal point for the agency?
- FDA’s Drug Trials Snapshots program shares information about who is participating in clinical trials for FDA-approved drugs. What is the program and what are the key takeaways?
- What role can public health workers play in supporting diversity in clinical trials?